Published in Blood Weekly, October 19th, 2006
"L-asparaginase is a crucial drug in childhood ALL induction therapy, but much debate remains regarding the optimal formulation and dosage. As MRD can accurately measure extremely low levels of lymphoblasts, it is a sensitive reflection of leukemia cell kill," researchers in Singapore reported.
"We utilized MRD to compare the efficacy of Erwinia-asparaginase (Envinia-asp) and E. coli-asparaginase (E....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.